Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 18 November 2003
Vol. 2003, Issue 209, p. tw450
[DOI: 10.1126/stke.2092003TW450]


BRAIN DISEASE ROCK and Rho Beat Beta Amyloid

Some nonsteroidal anti-inflammatory drugs have been shown to reduce the secretion of the β-amyloid peptide. Zhou et al. show that this effect may be due to their interaction with the small guanosine triphosphatase Rho and its effector kinase ROCK. Directly inhibiting ROCK led to reductions in the levels of β-amyloid peptide observed in the brains of Alzheimer's disease model mice. Thus, Rho and ROCK may be important players in Alzheimer's pathogenesis and may represent targets for therapeutic intervention.

Y. Zhou, Y. Su, B. Li, F. Liu, J. W. Ryder, X. Wu, P. A. Gonzalez-DeWhitt, V. Gelfanova, J. E. Hale, P. C. May, S. M. Paul, B. Ni, Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Aβ42 by inhibiting Rho. Science 302, 1215-1217 (2003). [Abstract] [Full Text]

Citation: ROCK and Rho Beat Beta Amyloid. Sci. STKE 2003, tw450 (2003).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882